Antihypertensive effects of mibefradil: A double-blind comparison with diltiazem CD
Author:
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference19 articles.
1. In vitro pharmacologic profile of Ro 40--5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action;Osterrieder;J Cardiovasc Pharmacol,1989
2. Selective inhibition of T-type Ca2+ channels by Ro 40--5967;Mishra;Circ Res,1994
3. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40--5967 and verapamil: Relation to negative inotropy;Liang-Min;Eur J Pharmacol,1991
4. The Ca++ channel blocker Ro 40--5967 blocks differently T-type and L-type Ca++ channels;Mehrke;J Pharmacol Exp Ther,1994
5. Protein families that mediate Ca2+ signaling in the cardiovascular system;Katz;Am J Cardiol,1996
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate – a meta-analysis of randomized trials;Journal of Hypertension;2011-07
2. Has the role of calcium channel blockers in treating hypertension finally been defined?;Current Hypertension Reports;2003-07
3. T-channel—selective calcium channel blockade: a review of published data and therapeutic potential;Current Therapeutic Research;1998-11
4. Mibefradil: A New Class of Calcium-Channel Antagonists;Annals of Pharmacotherapy;1998-06
5. Mibefradil, a Pharmacologically Distinct Calcium Antagonist;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;1998-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3